Accession Number: | 0001104659-21-153090 |
Date: | 2021-12-21 |
Issuer: | IVERIC BIO, INC. (ISEE) |
Original Submission Date: |
WESTBY KEITH
C/O IVERIC BIO, INC.
5 PENN PLAZA, SUITE 2372
NEW YORK,, NY 10001
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-12-21 | S | 20,000 | d | $15.89 | 108,058 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | the sale reported on this form was effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 16, 2021. |
f2 | the sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $15.58 to $16.10 per share on december 21, 2021. the reporting person undertakes to provide upon request by the staff of the securities exchange commission, the registrant or a security holder of the registrant, information regarding the number of shares sold at each price within the range. |